Envista Holdings Corporation participated in the 2026 Global Healthcare Conference, featuring a Q&A session with CEO Paul Keel and CFO Eric Hammes. The discussion included insights into the company's dental consumables and equipment business. No prepared remarks were given, focusing instead on direct interaction with analysts and attendees. This engagement highlights Envista's ongoing communication with investors and industry stakeholders.
Envista Holdings Corporation's presentation at the 2026 Global Healthcare Conference provides context for healthcare sector activity. For readers following healthcare stocks, here is Pluang's market snapshot as of Sep 16, 2026 00:52 WIB: out of 91 priced US health-sector stocks, 28 rose and 63 fell. Notable movers include Illumina, Inc. (ILMN) with a price of USD 225.13 and a 1-day change of +8.13%, 10X Genomics Inc (TXG) at USD 75.05 with +7.05%, and BridgeBio Pharma Inc (BBIO) at USD 67.64 with -6.56%.
Share-ify introduced the S.A.F.E. Score™, an AI-powered forecasting engine designed to enhance supplier risk intelligence within its food safety and compliance solutions. This tool analyzes diverse data such as audit results, recall history, and insp...
EquipmentShare, a major U.S. construction equipment rental and technology provider, will announce its fiscal third quarter 2026 financial results after market close on November 9, 2026. The company will host a conference call for investors and analys...
Atlantic American Corporation received a Nasdaq Staff Delisting Determination due to missing its 2025 annual and 2026 quarterly SEC reports by the extended October 12 deadline. The company has since filed the 2025 annual report and is working to subm...
Randstad reported revenue and earnings that exceeded expectations, driven by improving business trends and key labor markets. This positive performance signals momentum in the employment services sector. RBC Capital maintained a 'Sector Perform' rati...
MSC Industrial Supply reported strong Q4 results with revenue rising 10.3% year-over-year to about $1.08 billion, surpassing estimates. Adjusted earnings per share increased to $1.45 from $1.09, also beating expectations. Full-year sales grew 6.4% to...
